Profile data is unavailable for this security.
About the company
PT Phapros Tbk is an Indonesia-based pharmaceutical company. The Company's business pillars consist of branded/ethical prescription medicines: hospitals and pharmacies in addition to other healthcare institutions; over-the-counter drugs: pharmacies, retail; generic prescription drugs: government institutions and hospitals; toll-in manufacturing, and medical device. It offers medicines for cardiovascular and hematopoietic, gastrointestinal and hepatobiliary, hormone Genito, urinary endocrine and metabolic, vitamins and minerals nutrition, dermatology, local anesthesia, immune & allergy, and others. The Company's medical devices include ACS MB system, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho and NPC-STRIP G. Its branded drugs include Colkatriol 0.25 mcg 30 Cap, Diafac XR, Diafac 500 mg 10 tablets, Spirolactone 25 & 1, Dextamine Syrup 60 ml, Diapros Tablet, Proinfarction, anemone, Pladel, and others. The Company also operates calibration laboratory.
- Revenue in IDR (TTM)1.07tn
- Net income in IDR-4.21bn
- Incorporated--
- Employees1.49k
- LocationPhapros Tbk PTLantai Dasar, Gedung RNIJl. Denpasar Raya Kav. DIIIKuninganJAKARTA SELATAN 12950IndonesiaIDN
- Phone+62 215762709
- Fax+62 215763910
- Websitehttps://www.phapros.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Pharma Indonesia Tbk PT | 2.75tn | 187.70bn | 146.44bn | 199.00 | -- | -- | 0.6426 | 0.0533 | 52,139.53 | 52,139.53 | 763,202.60 | 233,457.70 | 1.97 | 6.40 | 8.68 | 13,806,680,000.00 | 13.49 | 11.41 | 19.80 | 15.86 | 10.84 | 12.57 | 6.83 | 6.78 | 1.40 | 47.01 | 0.0067 | -- | 17.45 | 4.49 | 7.39 | 8.11 | -14.93 | -- |
| Pyridam Farma Tbk PT | 702.07bn | -85.22bn | 305.00bn | 1.19k | -- | 0.8547 | -- | 0.4344 | -159.27 | -159.27 | 1,312.08 | 666.88 | 0.4616 | 1.87 | 4.16 | 588,489,200.00 | -5.60 | 6.31 | -6.96 | 8.07 | 42.06 | 42.56 | -12.14 | 8.83 | 1.17 | 0.0208 | 0.7343 | -- | -1.87 | 22.89 | -130.96 | -- | 2.93 | -- |
| Phapros Tbk PT | 1.07tn | -4.21bn | 420.00bn | 1.49k | -- | 0.5747 | 9.23 | 0.3918 | -5.01 | -5.01 | 1,276.14 | 869.98 | 0.5694 | 1.79 | 1.75 | 708,496,600.00 | -0.2287 | 3.51 | -0.4104 | 6.82 | 50.05 | 52.91 | -0.4016 | 6.06 | 0.8648 | 0.8545 | 0.5308 | -- | 11.13 | 3.12 | 153.55 | -25.86 | -29.64 | -- |
| Ikapharmindo Putramas Tbk PT | -100.00bn | -100.00bn | 495.29bn | 983.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.68 | -- | 104.02 | -- | -- | -- |
| Indofarma Tbk PT | 684.91bn | -437.05bn | 545.47bn | 1.09k | -- | -- | -- | 0.7964 | -141.03 | -141.03 | 221.00 | -33.99 | 0.4147 | 3.14 | 3.13 | 578,473,800.00 | -26.46 | -6.07 | -75.37 | -12.29 | -25.73 | 14.39 | -63.81 | -5.63 | 0.4962 | -15.51 | 1.16 | -- | -60.58 | -6.85 | -1,040.12 | -- | -32.32 | -- |
| Darya-Varia Laboratoria Tbk PT | 1.89tn | 146.34bn | 1.60tn | 1.27k | 10.94 | 1.14 | 7.62 | 0.847 | 130.66 | 130.66 | 1,688.29 | 1,253.96 | 0.9335 | 1.91 | 3.01 | 1,490,061,000.00 | 7.22 | 8.45 | 9.55 | 11.41 | 51.58 | 52.21 | 7.74 | 8.83 | 1.96 | 51.88 | 0.001 | -- | -1.36 | 2.16 | -2.03 | -6.12 | 16.57 | -- |
| Merck Tbk PT | 961.43bn | 178.24bn | 1.80tn | 390.00 | 10.10 | 2.26 | 8.55 | 1.87 | 397.85 | 397.85 | 2,146.06 | 1,776.52 | 0.9636 | 1.50 | 8.08 | 2,465,215,000.00 | 17.86 | 12.78 | 21.85 | 18.12 | 41.65 | 40.53 | 18.54 | 14.06 | 2.73 | -- | 0.0223 | -- | -14.51 | 9.46 | -0.8884 | 36.67 | -3.13 | -- |
